• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct23
FENGYUAN PHARMACEUTICAL released FY2025 9 Months Earnings on October 23 (BJT), actual revenue CNY 3.125 B, actual EPS CNY 0.2157
15:00
Fengyuan Pharmaceutical released FY2025 Q3 earnings on October 23 (BJT), actual revenue CNY 1.098 B, actual EPS CNY 0.0516
15:00
Aug21
Fengyuan Pharmaceutical released FY2025 Q2 earnings on August 21 After-Market (BJT), actual revenue CNY 1.086 B, actual EPS CNY 0.0822
01:00
Fengyuan Pharmaceutical released FY2025 Semi-Annual Earnings on August 21 After-Market BJT, actual revenue CNY 2.027 B, actual EPS CNY 0.1641
01:00
Aug14
Fengyuan Pharmaceutical to Release FY2025 Semi-Annual Earnings on August 22, 2025 (BJT)
00:31
Jul9
Fengyuan Pharmaceutical Maintains CCC ESG Rating, Ranking Improves
01:15

Schedules & Filings

Schedules
Filings
Oct23
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 1.098 B, Net Income 24.01 M, EPS 0.0516

Aug22
Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug21
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 1.086 B, Net Income 38.26 M, EPS 0.0822

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More